Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Lung Cancer

  Free Subscription


Articles published in Oncogene

Retrieve available abstracts of 60 articles:
HTML format



Single Articles


    June 2021
  1. LIANG SK, Hsu CC, Song HL, Huang YC, et al
    FOXM1 is required for small cell lung cancer tumorigenesis and associated with poor clinical prognosis.
    Oncogene. 2021 Jun 21. pii: 10.1038/s41388-021-01895.
    PubMed     Abstract available


  2. LIU W, Huang Y, Wang D, Han F, et al
    MPDZ as a novel epigenetic silenced tumor suppressor inhibits growth and progression of lung cancer through the Hippo-YAP pathway.
    Oncogene. 2021 Jun 9. pii: 10.1038/s41388-021-01857.
    PubMed     Abstract available


  3. YANG X, Chen Y, Zhou Y, Wu C, et al
    GPC5 suppresses lung cancer progression and metastasis via intracellular CTDSP1/AhR/ARNT signaling axis and extracellular exosome secretion.
    Oncogene. 2021 Jun 2. pii: 10.1038/s41388-021-01837.
    PubMed     Abstract available


    April 2021
  4. XU L, Liu W, Li T, Hu Y, et al
    Long non-coding RNA SMASR inhibits the EMT by negatively regulating TGF-beta/Smad signaling pathway in lung cancer.
    Oncogene. 2021 Apr 30. pii: 10.1038/s41388-021-01760.
    PubMed     Abstract available


    March 2021
  5. MORENO T, Monterde B, Gonzalez-Silva L, Betancor-Fernandez I, et al
    ARID2 deficiency promotes tumor progression and is associated with higher sensitivity to chemotherapy in lung cancer.
    Oncogene. 2021 Mar 19. pii: 10.1038/s41388-021-01748.
    PubMed     Abstract available


  6. CHENG C, Pei X, Li SW, Yang J, et al
    CRISPR/Cas9 library screening uncovered methylated PKP2 as a critical driver of lung cancer radioresistance by stabilizing beta-catenin.
    Oncogene. 2021 Mar 19. pii: 10.1038/s41388-021-01692.
    PubMed     Abstract available


  7. MA S, Zhang L, Ren Y, Dai W, et al
    Epiregulin confers EGFR-TKI resistance via EGFR/ErbB2 heterodimer in non-small cell lung cancer.
    Oncogene. 2021 Mar 9. pii: 10.1038/s41388-021-01734.
    PubMed     Abstract available


  8. MENG C, Zhan J, Chen D, Shao G, et al
    The deubiquitinase USP11 regulates cell proliferation and ferroptotic cell death via stabilization of NRF2 USP11 deubiquitinates and stabilizes NRF2.
    Oncogene. 2021;40:1706-1720.
    PubMed     Abstract available


    February 2021
  9. KWON OS, Lee H, Kong HJ, Kwon EJ, et al
    Correction to: Connectivity map-based drug repositioning of bortezomib to reverse the metastatic effect of GALNT14 in lung cancer.
    Oncogene. 2021 Feb 11. pii: 10.1038/s41388-021-01642.
    PubMed    


  10. ZHAO L, Wu X, Zheng J, Dong D, et al
    DNA methylome profiling of circulating tumor cells in lung cancer at single base-pair resolution.
    Oncogene. 2021 Feb 9. pii: 10.1038/s41388-021-01657.
    PubMed     Abstract available


  11. LIU PI, Chang AC, Lai JL, Lin TH, et al
    Melatonin interrupts osteoclast functioning and suppresses tumor-secreted RANKL expression: implications for bone metastases.
    Oncogene. 2021;40:1503-1515.
    PubMed     Abstract available


  12. CHENG FJ, Chen CH, Tsai WC, Wang BW, et al
    Cigarette smoke-induced LKB1/AMPK pathway deficiency reduces EGFR TKI sensitivity in NSCLC.
    Oncogene. 2021;40:1162-1175.
    PubMed     Abstract available


    January 2021
  13. LIN S, Zhang X, Huang G, Cheng L, et al
    Myeloid-derived suppressor cells promote lung cancer metastasis by CCL11 to activate ERK and AKT signaling and induce epithelial-mesenchymal transition in tumor cells.
    Oncogene. 2021 Jan 15. pii: 10.1038/s41388-020-01605.
    PubMed     Abstract available


  14. GAROFALO M, Quintavalle C, Di Leva G, Zanca C, et al
    Correction: MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer.
    Oncogene. 2021 Jan 4. pii: 10.1038/s41388-020-01608.
    PubMed    


  15. ALSAFADI S, Dayot S, Tarin M, Houy A, et al
    Genetic alterations of SUGP1 mimic mutant-SF3B1 splice pattern in lung adenocarcinoma and other cancers.
    Oncogene. 2021;40:85-96.
    PubMed     Abstract available


  16. HE D, Wang D, Lu P, Yang N, et al
    Single-cell RNA sequencing reveals heterogeneous tumor and immune cell populations in early-stage lung adenocarcinomas harboring EGFR mutations.
    Oncogene. 2021;40:355-368.
    PubMed     Abstract available


  17. TANG L, Xiong W, Zhang L, Wang D, et al
    circSETD3 regulates MAPRE1 through miR-615-5p and miR-1538 sponges to promote migration and invasion in nasopharyngeal carcinoma.
    Oncogene. 2021;40:307-321.
    PubMed     Abstract available


  18. LIU X, Wang F, Xu C, Chen X, et al
    Genomic origin and intratumor heterogeneity revealed by sequencing on carcinomatous and sarcomatous components of pulmonary sarcomatoid carcinoma.
    Oncogene. 2021;40:821-832.
    PubMed     Abstract available


  19. LIN WH, Chang YW, Hong MX, Hsu TC, et al
    STAT3 phosphorylation at Ser727 and Tyr705 differentially regulates the EMT-MET switch and cancer metastasis.
    Oncogene. 2021;40:791-805.
    PubMed     Abstract available


  20. GUHA P, Gardell J, Rabinowitz B, Lopes M, et al
    Monocytic and granulocytic myeloid-derived suppressor cell plasticity and differentiation are organ-specific.
    Oncogene. 2021;40:693-704.
    PubMed     Abstract available


    December 2020
  21. CUI C, Liu Y, Gerloff D, Rohde C, et al
    NOP10 predicts lung cancer prognosis and its associated small nucleolar RNAs drive proliferation and migration.
    Oncogene. 2020 Dec 7. pii: 10.1038/s41388-020-01570.
    PubMed     Abstract available


    November 2020
  22. LIU Y, Wang X, Li W, Xu Y, et al
    Oroxylin A reverses hypoxia-induced cisplatin resistance through inhibiting HIF-1alpha mediated XPC transcription.
    Oncogene. 2020;39:6893-6905.
    PubMed     Abstract available


    October 2020
  23. NIMMAKAYALA RK, Leon F, Rachagani S, Rauth S, et al
    Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma.
    Oncogene. 2020 Oct 27. pii: 10.1038/s41388-020-01518.
    PubMed     Abstract available


  24. TUMBRINK HL, Heimsoeth A, Sos ML
    The next tier of EGFR resistance mutations in lung cancer.
    Oncogene. 2020 Oct 15. pii: 10.1038/s41388-020-01510.
    PubMed     Abstract available


  25. SHEN H, Wang GC, Li X, Ge X, et al
    S6K1 blockade overcomes acquired resistance to EGFR-TKIs in non-small cell lung cancer.
    Oncogene. 2020 Oct 9. pii: 10.1038/s41388-020-01497.
    PubMed     Abstract available


  26. OCHIENG JK, Kundu ST, Bajaj R, Leticia Rodriguez B, et al
    MBIP (MAP3K12 binding inhibitory protein) drives NSCLC metastasis by JNK-dependent activation of MMPs.
    Oncogene. 2020;39:6719-6732.
    PubMed     Abstract available


  27. LENG X, Wang J, An N, Wang X, et al
    Histone 3 lysine-27 demethylase KDM6A coordinates with KMT2B to play an oncogenic role in NSCLC by regulating H3K4me3.
    Oncogene. 2020;39:6468-6479.
    PubMed     Abstract available


    September 2020
  28. JESSEN C, Kress JKC, Baluapuri A, Hufnagel A, et al
    The transcription factor NRF2 enhances melanoma malignancy by blocking differentiation and inducing COX2 expression.
    Oncogene. 2020 Sep 25. pii: 10.1038/s41388-020-01477.
    PubMed     Abstract available


  29. WANG K, Ji W, Yu Y, Li Z, et al
    Correction: FGFR1-ERK1/2-SOX2 axis promotes cell proliferation, epithelial-mesenchymal transition, and metastasis in FGFR1-amplified lung cancer.
    Oncogene. 2020 Sep 7. pii: 10.1038/s41388-020-01441.
    PubMed     Abstract available


  30. BAJAJ R, Kundu ST, Grzeskowiak CL, Fradette JJ, et al
    IMPAD1 and KDELR2 drive invasion and metastasis by enhancing Golgi-mediated secretion.
    Oncogene. 2020;39:5979-5994.
    PubMed     Abstract available


    August 2020
  31. ZHANG X, Li F, Tang Y, Ren Q, et al
    miR-21a in exosomes from Lewis lung carcinoma cells accelerates tumor growth through targeting PDCD4 to enhance expansion of myeloid-derived suppressor cells.
    Oncogene. 2020 Aug 27. pii: 10.1038/s41388-020-01406.
    PubMed     Abstract available


  32. LI C, Zhao W, Pan X, Li X, et al
    LncRNA KTN1-AS1 promotes the progression of non-small cell lung cancer via sponging of miR-130a-5p and activation of PDPK1.
    Oncogene. 2020 Aug 20. pii: 10.1038/s41388-020-01427.
    PubMed     Abstract available


  33. ZHU Y, Li J, Bo H, He D, et al
    LINC00467 is up-regulated by TDG-mediated acetylation in non-small cell lung cancer and promotes tumor progression.
    Oncogene. 2020 Aug 14. pii: 10.1038/s41388-020-01421.
    PubMed     Abstract available


  34. WANG M, Long K, Li E, Li L, et al
    DNA polymerase beta modulates cancer progression via enhancing CDH13 expression by promoter demethylation.
    Oncogene. 2020;39:5507-5519.
    PubMed     Abstract available


    July 2020
  35. ROH JI, Lee J, Sung YH, Oh J, et al
    Impaired AKT signaling and lung tumorigenesis by PIERCE1 ablation in KRAS-mutant non-small cell lung cancer.
    Oncogene. 2020 Jul 29. pii: 10.1038/s41388-020-01399.
    PubMed     Abstract available


  36. MENG DF, Sun R, Liu GY, Peng LX, et al
    S100A14 suppresses metastasis of nasopharyngeal carcinoma by inhibition of NF-kB signaling through degradation of IRAK1.
    Oncogene. 2020;39:5307-5322.
    PubMed     Abstract available


  37. HYSLOP SR, Alexander M, Thai AA, Kersbergen A, et al
    Targeting platelets for improved outcome in KRAS-driven lung adenocarcinoma.
    Oncogene. 2020;39:5177-5186.
    PubMed     Abstract available


    June 2020
  38. ZHANG X, Yang L, Szeto P, Abali GK, et al
    The Hippo pathway oncoprotein YAP promotes melanoma cell invasion and spontaneous metastasis.
    Oncogene. 2020 Jun 19. pii: 10.1038/s41388-020-1362.
    PubMed     Abstract available


  39. KOYEN AE, Madden MZ, Park D, Minten EV, et al
    EZH2 has a non-catalytic and PRC2-independent role in stabilizing DDB2 to promote nucleotide excision repair.
    Oncogene. 2020;39:4798-4813.
    PubMed     Abstract available


    May 2020
  40. KWON OS, Lee H, Kong HJ, Kwon EJ, et al
    Connectivity map-based drug repositioning of bortezomib to reverse the metastatic effect of GALNT14 in lung cancer.
    Oncogene. 2020 May 9. pii: 10.1038/s41388-020-1316.
    PubMed     Abstract available


  41. HSIEN LAI S, Zervoudakis G, Chou J, Gurney ME, et al
    PDE4 subtypes in cancer.
    Oncogene. 2020;39:3791-3802.
    PubMed     Abstract available


  42. YU L, Dong L, Li H, Liu Z, et al
    Ubiquitination-mediated degradation of SIRT1 by SMURF2 suppresses CRC cell proliferation and tumorigenesis.
    Oncogene. 2020;39:4450-4464.
    PubMed     Abstract available


    April 2020
  43. TIAN Q, Yuan P, Quan C, Li M, et al
    Phosphorylation of BCKDK of BCAA catabolism at Y246 by Src promotes metastasis of colorectal cancer.
    Oncogene. 2020 Apr 1. pii: 10.1038/s41388-020-1262.
    PubMed     Abstract available


  44. LI F, Li Z, Han Q, Cheng Y, et al
    Enhanced autocrine FGF19/FGFR4 signaling drives the progression of lung squamous cell carcinoma, which responds to mTOR inhibitor AZD2104.
    Oncogene. 2020;39:3507-3521.
    PubMed     Abstract available


  45. LI Y, Zhang H, Fan L, Mou J, et al
    MiR-629-5p promotes the invasion of lung adenocarcinoma via increasing both tumor cell invasion and endothelial cell permeability.
    Oncogene. 2020;39:3473-3488.
    PubMed     Abstract available


  46. KASIRI S, Chen B, Wilson AN, Reczek A, et al
    Stromal Hedgehog pathway activation by IHH suppresses lung adenocarcinoma growth and metastasis by limiting reactive oxygen species.
    Oncogene. 2020;39:3258-3275.
    PubMed     Abstract available


  47. YIN H, Jiang Z, Feng X, Ji Z, et al
    Identification of Sca-1(+)Abcg1(+) bronchioalveolar epithelial cells as the origin of lung adenocarcinoma in Gprc5a-knockout mouse model through the interaction between lung progenitor AT2 and Lgr5 cells.
    Oncogene. 2020;39:3754-3773.
    PubMed     Abstract available


  48. WANG T, Jing B, Xu D, Liao Y, et al
    PTGES/PGE2 signaling links immunosuppression and lung metastasis in Gprc5a-knockout mouse model.
    Oncogene. 2020;39:3179-3194.
    PubMed     Abstract available


    March 2020
  49. WANG Y, Ma R, Liu B, Kong J, et al
    SNP rs17079281 decreases lung cancer risk through creating an YY1-binding site to suppress DCBLD1 expression.
    Oncogene. 2020 Mar 30. pii: 10.1038/s41388-020-1278.
    PubMed     Abstract available


  50. YANG W, Khoury E, Guo Q, Prabhu SA, et al
    MNK1 signaling induces an ANGPTL4-mediated gene signature to drive melanoma progression.
    Oncogene. 2020 Mar 4. pii: 10.1038/s41388-020-1240.
    PubMed     Abstract available


  51. CHAN YC, Chang YC, Chuang HH, Yang YC, et al
    Overexpression of PSAT1 promotes metastasis of lung adenocarcinoma by suppressing the IRF1-IFNgamma axis.
    Oncogene. 2020;39:2509-2522.
    PubMed     Abstract available


    February 2020
  52. HUANG J, Lan X, Wang T, Lu H, et al
    Targeting the IL-1beta/EHD1/TUBB3 axis overcomes resistance to EGFR-TKI in NSCLC.
    Oncogene. 2020;39:1739-1755.
    PubMed     Abstract available


  53. ZHANG Q, Fan H, Liu H, Jin J, et al
    WNT5B exerts oncogenic effects and is negatively regulated by miR-5587-3p in lung adenocarcinoma progression.
    Oncogene. 2020;39:1484-1497.
    PubMed     Abstract available


    January 2020
  54. ZHANG J, Lin X, Wu L, Huang JJ, et al
    Aurora B induces epithelial-mesenchymal transition by stabilizing Snail1 to promote basal-like breast cancer metastasis.
    Oncogene. 2020 Jan 29. pii: 10.1038/s41388-020-1165.
    PubMed     Abstract available


  55. WU X, Zhang X, Yu L, Zhang C, et al
    Zinc finger protein 367 promotes metastasis by inhibiting the Hippo pathway in breast cancer.
    Oncogene. 2020 Jan 27. pii: 10.1038/s41388-020-1166.
    PubMed     Abstract available


  56. DIAS MM, Adamoski D, Dos Reis LM, Ascencao CFR, et al
    GLS2 is protumorigenic in breast cancers.
    Oncogene. 2020;39:690-702.
    PubMed     Abstract available


  57. SMEESTER BA, Slipek NJ, Pomeroy EJ, Bomberger HE, et al
    SEMA4C is a novel target to limit osteosarcoma growth, progression, and metastasis.
    Oncogene. 2020;39:1049-1062.
    PubMed     Abstract available


  58. WANG D, Cheng X, Li Y, Guo M, et al
    C/EBPdelta-Slug-Lox1 axis promotes metastasis of lung adenocarcinoma via oxLDL uptake.
    Oncogene. 2020;39:833-848.
    PubMed     Abstract available


    December 2019
  59. FANG R, Xu F, Shi H, Wu Y, et al
    LAMTOR5 raises abnormal initiation of O-glycosylation in breast cancer metastasis via modulating GALNT1 activity.
    Oncogene. 2019 Dec 13. pii: 10.1038/s41388-019-1146.
    PubMed     Abstract available


    October 2019
  60. ZHANGYUAN G, Wang F, Zhang H, Jiang R, et al
    VersicanV1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR-PI3K-AKT pathway.
    Oncogene. 2019 Oct 11. pii: 10.1038/s41388-019-1052.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: